4Fraunfelder FW. Corneal toxicity from topical ocular and systemic medications. Cornea,2006,25 : 1133-1138.
5Hazin R, Ibrahimi OA, Hazin MI, et al. Stevens-Johnson syndrome : pathogenesis, diagnosis, and management. Ann Med, 2008,40 : 129-138.
6Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol, 1998, 82:39-42.
7Dart J. Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye,2003,17:886-892.
8Leeming JP. Treatment of ocular infections with topical antibacterials. Clin Pharmacokinet, 1999,37:351-360.
9Tullo A. Pathogenesis and management of herpes simplex virus keratitis. Eye,2003,17:919-922.
10Chambless SL, Trocme S. Developments in ocular allergy. Curr Opin Allergy Clin Immunol,2004 ,4 :431-434.
3Katsimpris JM,Sarantoulakon M,Kordelon A,et al. Clini-cal findings in patients with topical anaesthetic abuse ker-atitis :a report of five caese. Klin Monatsbl Augenheilkd,2007,224:303 -308.
4Lin JC,Rapuano CJ,Laibson PR,et al. Comealmelting as-sociated with use of topical nonsteroidal anti - inflammato-ry drugs after ocular surgery. Arch Ophthalnol ,2007 ,118 :1129 -1132.
5Daniel CS, Fraser SG, Dart JK, et al. An unusual presentation of dia- betic neuropathy[ J]. British Journal of Ophthalmology,2001,85 ( 5 ) : 628 - 629.
6Rosenberg ME, Tervo TM, Immonen I J, et al. Corneal structure and sensitivity in type diabetes mellitus [ J ]. Visual Science, 2010,41 (10) :2915 -2921.
